148 related articles for article (PubMed ID: 31127778)
1. Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease.
Hamina A; Taipale H; Karttunen N; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
J Alzheimers Dis; 2019; 69(3):807-816. PubMed ID: 31127778
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2019; 68(1):127-136. PubMed ID: 30775987
[TBL] [Abstract][Full Text] [Related]
3. Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease.
Lintula E; Tiihonen M; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Hamina A
Drugs Aging; 2020 Mar; 37(3):193-203. PubMed ID: 31879863
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study.
Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Karttunen N; Pylkkänen L; Tiihonen J; Hartikainen S
Pain; 2017 Feb; 158(2):252-260. PubMed ID: 28092324
[TBL] [Abstract][Full Text] [Related]
5. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Am Geriatr Soc; 2020 Mar; 68(3):595-602. PubMed ID: 31912482
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of pneumonia in persons with and without Alzheimer's disease: a matched cohort study.
Järvinen H; Tolppanen AM; Hartikainen S
BMC Geriatr; 2023 Apr; 23(1):227. PubMed ID: 37038120
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
Järvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
J Alzheimers Dis; 2018; 64(2):437-445. PubMed ID: 29914029
[TBL] [Abstract][Full Text] [Related]
8. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
[TBL] [Abstract][Full Text] [Related]
9. Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study.
Taipale H; Hamina A; Karttunen N; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
Pain; 2019 Feb; 160(2):417-423. PubMed ID: 30325873
[TBL] [Abstract][Full Text] [Related]
10. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
[TBL] [Abstract][Full Text] [Related]
11. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
[TBL] [Abstract][Full Text] [Related]
12. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease.
Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur J Pain; 2017 Apr; 21(4):658-667. PubMed ID: 27862681
[TBL] [Abstract][Full Text] [Related]
13. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.
Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
BMC Geriatr; 2016 Dec; 16(1):204. PubMed ID: 27908278
[TBL] [Abstract][Full Text] [Related]
14. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.
Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
Int J Geriatr Psychiatry; 2019 Feb; 34(2):280-288. PubMed ID: 30370943
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease.
Tolppanen AM; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Taipale H
Chest; 2016 Dec; 150(6):1233-1241. PubMed ID: 27298071
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.
Lampela P; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
J Alzheimers Dis; 2017; 56(1):119-128. PubMed ID: 27911327
[TBL] [Abstract][Full Text] [Related]
17. Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland.
Bell SJ; Laitinen ML; Lavikainen P; Lönnroos E; Uosukainen H; Hartikainen S
Pain; 2011 Mar; 152(3):543-547. PubMed ID: 21247697
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study.
Sarycheva T; Lavikainen P; Taipale H; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
J Am Heart Assoc; 2018 Sep; 7(18):e009742. PubMed ID: 30371186
[TBL] [Abstract][Full Text] [Related]
19. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
Rajamaki B; Hartikainen S; Tolppanen AM
BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
[TBL] [Abstract][Full Text] [Related]
20. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen AM; Sund R; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2017 May; 32(3):135-141. PubMed ID: 28072593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
